Tumor Specific Antigens
Antibodies Targeting Tumor Specific Antigens

bioxcell.com

Tumor Specific Antigens
Antigen

Reactivity

Application

Clone

Catalog
NumberIsotypeControl

CA19-9human

IHCP, IF, FC

1116-NS-19-9

BE0355

BE0083

CD19

human

FC, Functional assay, IF

4G7

BE0281

BE0083

CD19

mouse

in vivo B cell depletion, in vivo CD19 neutralization, in vitro B cell negative selection, FC

1D3

BE0150BE0089CD71 (TfR1)

human

FC, IHC-F

OKT9BE0023

BE0083

CD71 (TfR1)

human

WB, IP, FC

5E9C11BE0343

BE0083

CD71 (TfR1)

mousein vivo depletion of CD71+ cells

R17 217.1.3/TIB-219

BP0175BP0089CD71 (TfR1)

mousein vivo depletion of CD71+ cells, IF, IHC-F, WB

8D3

BP0329BP0089CD71 (TfR1)

rat/mouse

Targeted drug delivery to the brain, IHC-F, FC

OX-26

BE0331

BE0085

CD172a (SIRPα)mousein vivo and in vitro SIRPα blocking

P84

BE0322BE0088CD200 (OX2)

mousein vivo and in vitro CD200 blockade, IHCF, IF, FC

OX-90

BE0299BE0089CD220 (insulin receptor)

human

WB

IR 83-22

BE0338BE0083

CD326 (EpCAM)

mouseIHCF, IF, FC, WB

G8.8

BE0346

BE0089CEACAM 1/3/5/6/8

human

WB, ELISA, IF, IHCP, FC

6G5j

BE0362BE0083

CEACAM7

human

WB, ELISA, IP, IHC, FC

P3-7B

BE0363BE0083c-Kit (CD117)

mousein vivo mast cell depletion, in vivo c-Kit+ cell depletion, in vitro c-Kit neutralization, IP, FC

ACK2

BE0293BE0090E-Cadherin (CD324)

mousein vivo and in vitro E-Cadherin neutralization, IF, IP, WB

DECMA-1

BE0352BE0088

EGFR

human

in vitro EGFR blockade, in vivo EGFR blockade in xenografts, Functional assay, WB, IP, IHCP, IF, FC

528

BE0279BE0085

EGFR

human

in vitro EGFR blockade, in vivo EGFR blockade in xenografts, Functional assay, WB

225

BE0278BE0083

EGFR

human

in vivo EGFR blockade in xenografts, in vitro EGFR blockade, IP

425

BE0375

BE0085

EGFR

human

EGFR blockade, ELISA, FC

Cetuximab

SIM0002

BP0297

EphA2

human

IHCP, Functional assay, IP

B2D6

BE0341

BE0086Ganglioside GD2

humanin vitro induction of apoptosis in GD2+ cells, in vivo inhibition of GD2+ tumor cell growth

14G2aBE0318BE0085

HER2

human

FC, ELISA, IHC, WB

Trastuzumab

SIM0005

BP0297

HER2

human/rat

in vivo and in vitro HER2 inhibition, IP, IF, FC

7.16.4

BE0277

BE0085

IL-27 p28

mousein vivo and in vitro IL-27 p28 neutralization, FC

MM27.7B1

BE0326

BE0085

LRP1 (CD91)

mouse/human/rat WB, IF, IP

11H4

BE0333BE0083

MUC1 (CD227)

humanin vivo administration in mouse xenograft models, in vitro cell cytotoxicity assay, IHCP, IF, WB

C595 (NCRC48) BE0336

BE0093

PD-L1

mousein vivo PD-L1 blockade, IF, IHCF, FC, WB

10F.9G2

BP0101BP0090PrP (prion protein)mouse/humanin vivo PrP blocking, WB

TW1BE0350

BE0085VEGFR-2

mousein vivo and in vitro blocking of VEGF/VEGFR-2 signaling, WB

DC101

BP0060BP0088

VLDL-R

mouse/rat/bovine

WB

IgG-6A6

BE0345

BE0083

IF Immunofluorescence | IHC-F Immunohistochemistry (frozen) | IHC-P Immunohistochemistry (paraffin) | WB Western blot | IP Immunoprecipitation | FC Flow cytometry(requires flurochrome conjugation)

For over 25 years, scientists have trusted Bio X Cell as their go-to source for in vivo functional grade antibodies. This isreflected in over 15,000 peer-reviewed publications citing Bio X Cell products. We understand this responsibility is ofparamount importance and remain committed to producing antibodies of unparalleled quality and consistency, enabling
our partners around the globe to accelerate research and discoveries.
Bio X Cellbioxcell.com | 1.866.787.3444
customerservice@bioxcell.com
Conditions: For Research Use Only. Not for use in diagnostic or theraputic procedures. Not for resale.
Bio X Cell, Bio X Cell Logo and all other trademarks are the property of Bio X Cell © 2022 Bio X Cell